1 report

Summary Viriom Inc (Viriom) focuses on the development of antivirals for HIV treatment and prevention. The company’s lead pipeline product candidate Elpida, is a bioavailable prodrug, and VM-1500A, a non-nucleoside HIV reverse transcriptase inhibitor. Its partner portfolio includes Roche, ChemDiv, Inc., Fox Chase Cancer...

  • Healthcare
  • Pharmaceutical
  • HIV Antiviral
  • Russia
  • World